Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A slow-growing malignant bone tumor arising from the remnants of the notochord and occurring in the clivus. It is characterized by a lobulated growth pattern, myxoid stroma formation, the presence of physaliphorous cells and cartilage.
No clinical trials have been registered for clivus chondroid chordoma.
4 publications have been identified in PubMed for clivus chondroid chordoma. Research spans Case Report / Case Series (75%) and Review / Meta-Analysis (25%).
Hamamoto K (2026). [PMID: 41954236](https://pubmed.ncbi.nlm.nih.gov/41954236/). *J Vet Diagn Invest*. [Case Report / Case Series]
Fürtös AM (2025). [PMID: 40371409](https://pubmed.ncbi.nlm.nih.gov/40371409/). *Medicine and pharmacy reports*. [Case Report / Case Series]
Fiore G (2024). [PMID: 38691853](https://pubmed.ncbi.nlm.nih.gov/38691853/). *Neurosurgical focus*. [Review / Meta-Analysis]
Tena Suck ML (2024). [PMID: 39233954](https://pubmed.ncbi.nlm.nih.gov/39233954/). *Cureus*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 5:33 AM UTC
Common questions about clivus chondroid chordoma
AI-curated news mentioning clivus chondroid chordoma
Updated May 26, 2026
A new study presents a chemoresistance test aimed at predicting personalized therapeutic responses in pediatric patients with clivus chordoma. This research could enhance treatment strategies for this rare tumor type.